Donepezil may delay nursing home admission in moderate to severe Alzheimer’s disease Discontinuing donepezil in Alzheimer’s patients as their disease worsens could double the risk of admission into a nursing home within a year, suggests a study published in The Lancet Neurology.…
Exposure to summer sun as a teenager could delay MS-onset In a Danish study of people with multiple sclerosis, researchers found that the disease started later in people who had spent time in the sun every day as a teenager.…
Fears over cancer risk with MS drug cladribine unfounded Cladribine was refused a licence for multiple sclerosis because of fears it increases the risk of cancer, but a new analysis finds no evidence to support this.…
Delayed dizziness after standing is early sign of orthostatic hypotension Patients who have a delayed drop in blood pressure are likely to see the condition progress, which is associated with the development of neurodegenerative conditions and a 50% mortality rate.…
Brains of CJD victims show signs of Alzheimer’s pathology Victims of Creutzfeldt–Jakob disease show evidence of Alzheimer’s pathology, suggests new research. But neuroscientists have quashed fears that people can “catch” Alzheimer’s.…
Stopping antihypertensives does not slow cognitive decline in older patients In patients over 75 years, low blood pressure can worsen cognitive decline, but researchers found that stopping antihypertensives did not help.…
Closing in on Alzheimer’s disease Knowledge about the neuropathology of Alzheimer’s disease has blossomed over the past few decades, leading to a better understanding of the condition and new ways to attack it.…
Data suggest that new Alzheimer’s drug solanezumab has disease-modifying properties A monoclonal antibody in development for the treatment of Alzheimer’s disease (AD) may have disease-modifying properties, according to new research.…
Glitazone drugs could play a role in prevention of Parkinson’s disease Patients who take glitazone drugs to manage their diabetes may have some protection from developing Parkinson’s disease, suggests new research.…
Clinical Pharmacist’s monthly news round-up: the top 10 in the past month What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…
